Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc

Applied Radiation and Isotopes

Volumn 70, Issue 6, 2012, Pages 974-979

  Pruszyński, Marek ^a   Majkowska Pilip, Agnieszka ^a   Loktionova, Natalia S ^b   Eppard, Elisabeth ^b   Roesch, Frank ^b  

^a INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY   (Poland)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

44Sc; 44Ti 44Sc radionuclide generator; DOTATOC; Molecular imaging; PET CT; Positron emitter

Indexed keywords

AMMONIUM ACETATE; BIFUNCTIONAL; CLINICAL INVESTIGATION; DOTATOC; HUMAN SERUM; LABELING PROCEDURES; MACRO-CYCLIC LIGANDS; METAL CATION; MOLECULAR TARGETING; OCTREOTIDE; PH RANGE; POSITRON EMITTERS; RADIOLABELING; RADIONUCLIDE GENERATORS; REACTION PARAMETERS; REACTION TEMPERATURE; STABLE COMPLEXES; TRIVALENT METAL CATIONS;

AMMONIUM COMPOUNDS; ELECTRONS; LIGANDS; MOLECULAR IMAGING; OPTIMIZATION; PEPTIDES; POSITIVE IONS; POSITRONS; RADIOISOTOPES; SODIUM CHLORIDE; SYNTHESIS (CHEMICAL);

SCANDIUM;

AMMONIUM ACETATE; CALCIUM ION; CHELATING AGENT; COPPER ION; EDETIC ACID; IRON; MACROCYCLIC COMPOUND; MANGANESE; PENTETIC ACID; PHOSPHATE BUFFERED SALINE; RADIOISOTOPE; SCANDIUM 44; SODIUM CHLORIDE; TETRAXETAN OCTREOTIDE[1 PHENYLALANINE 3 TYROSINE]; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG STABILITY; DRUG SYNTHESIS; HEATING; INCUBATION TIME; ISOTOPE ANALYSIS; ISOTOPE LABELING; MOLECULAR IMAGING; PH; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REACTION TIME; SOLID PHASE EXTRACTION;

CONTRAST MEDIA; ISOTOPE LABELING; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOPHARMACEUTICALS; SCANDIUM;

EID: 84860140648     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2012.03.005     Document Type: Article

References (30)

1. 44Ti half-life. Phys. Rev. Lett. 1998, 80:2550-2553.
2. 45Sc(p,2n) Process. Annual report 2005, Institute of Nuclear Chemistry, University of Mainz.
3. 68Ga generator and aspects of radiolabelling DOTA-peptides. Appl. Radiat. Isot. 2011, 69:308-315.
4. 177Lu at high specific activities. Eur. J. Nucl. Med. 2003, 30:917-920.
5. 11]-substance P: a pilot trial. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:1335-1344.
6. Elander N., Jones J.R., Lu S.Y., Stone-Elander S. Microwave-enhanced radiochemistry. Chem. Soc. Rev. 2000, 29:239-249.
7. 44Sc-based PET-radiopharmaceuticals. Radiochim. Acta 2010, 98:149-156.
8. Greene M.W., Hillman M. A scandium generator. Int. J. Appl. Radiat. Isot. 1967, 18:540-541.
9. Haddad F., Ferrer L., Guertin A., Carlier T., Michel N., Barbet J., Chatal J.-F. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:1377-1387.
10. Hao G., Singh A.N., Liu W., Sun X. PET with non-standard nuclides. Curr. Top. Med. Chem. 2010, 10:1096-1112.
11. 18F]-spiperone. J. Labelled Compd. Radiopharm. 1989, 26:391-392.
12. 44Sc - new radionuclide for PET technique. J. Labelled Compd. Radiopharm 2011, 54(S1):S53.
13. Kumar P., Wiebe L.I., Asikoglu M., Tandon M., McEwan A.J.B. Microwave-assisted (radio)halogenation of nitroimidazole-based hypoxia markers. Appl. Radiat. Isot. 2002, 57:697-703.
14. Lemaire C., Cantineau R., Christiaens L., Guillaume M. Radiofluorination of altanserine a potential serotonin receptor binding radiopharmaceutical for positron emission tomography. J. Labelled Compd. Radiopharm. 1989, 36:336-337.
15. Lodge M.A., Braess H., Mahmoud F., Suh J., Englar N., Geyser-Stoops S., Jenkins J., Bacharach S.L., Dilsizian V. Developments in nuclear cardiology: transition from single photon emission computed tomography to positron emission tomography-computed tomography. J Invasive Cardiol. 2005, 17:491-496.
16. Majkowska-Pilip A., Bilewicz A. Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals. J. Inorg. Biochem. 2011, 105:313-320.
17. Masuda Y., Okada Y., Murase I., Sekido E. Complex formation of scandium (III) with polyaminopolycarboxylic acids and isotachophoretic separation of scandium using complexation equilibria. Jpn. Anal. 1991, 40:215-220.
18. Mausner L.F., Joshi V., Kolsky K.L., Meinken G.E., Mease R.C., Sweet M.P., Srivastava S.C. Evaluation of chelating agents for radioimmunotherapy with scandium-47. J. Nucl. Med. 1995, 36:104P.
19. Mirza M.Y., Aziz A. A scandium generator. Radiochim. Acta 1969, 11:43-44.
20. 211At complexes as potential precursors for astatine radiopharmaceuticals. Part I: Synthesis. Bioconjugate Chem. 2008, 19:958-965.
21. 44Sc for medical application. Appl. Radiat. Isot. 2010, 68:1630-1641.
22. Qaim S.M. Decay data and production yields of some non-standard positron emitters used in PET. Q. J. Nucl. Med. Mol. Imaging 2008, 52:111-120.
23. Rahmim A., Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl. Med. Commun. 2008, 29:193-207.
24. 68Ga radiopharmaceutical chemistry. Curr. Top. Med. Chem. 2010, 16:1633-1668.
25. Rösch F., Knapp (Russ) F.F. Radionuclide generators. Handbook of Nuclear Chemistry. Radiochemistry and Radiopharmaceutical Chemistry in Life Sciences 2003, volume 4:89-97. Kluwer Academic Publishers, Dordrecht, Chapter 3.2.
26. Schumann, D., Horn, S., Neuhausen, J., 2007. Design of a 44Ti/44Sc generator system. Annual Report 2006, Paul Scherrer Institut & Universitaet Bern, January 2007, Villigen, Switzerland, p. 41.
27. 44Sc. Radiochim. Acta 1973, 19:196-198.
28. 111In-labelled analogue. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:1356-1367.
29. 68Ga-labeling of oligonucleotides. J. Labelled Compd. Radiopharm. 2004, 47:79-89.
30. 68Ga bioconjugates with high specific radioactivity. Bioconjugate Chem. 2004, 15:554-560.